Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 6 » default
Pharmacogenomics and Personalized Medicine
ISSN: 1178-7066
- View all (570)
- Volume 16, 2023 (46)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Archive: Volume 6, 2013
Patient selection and targeted treatment in the management of platinum-resistant ovarian cancer
Leamon PC, Lovejoy CD, Nguyen B
Pharmacogenomics and Personalized Medicine 2013, 6:113-125
Published Date: 25 September 2013
Delivering pharmacogenetic testing in a primary care setting
Mills R, Voora D, Peyser B, Haga SB
Pharmacogenomics and Personalized Medicine 2013, 6:105-112
Published Date: 18 September 2013
Lack of correlation between in silico projection of function and quantitative real-time PCR-determined gene expression levels in colon tissue
Penney RB, Lundgreen A, Yao-Borengasser A, Koroth-Edavana V, Williams S, Wolff R, Slattery ML, Kadlubar S
Pharmacogenomics and Personalized Medicine 2013, 6:99-103
Published Date: 9 September 2013
Association of CYP3A4/5, ABCB1 and ABCC2 polymorphisms and clinical outcomes of Thai breast cancer patients treated with tamoxifen
Sensorn I, Sirachainan E, Chamnanphol M, Pasomsub E, Trachu N, Supavilai P, Sukasem C, Pinthong D
Pharmacogenomics and Personalized Medicine 2013, 6:93-98
Published Date: 26 August 2013
CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factors
Sukasem C, Tunthong R, Chamnanphon M, Santon S, Jantararoungtong T, Koomdee N, Prommas S, Puangpetch A, Vathesatogkit P
Pharmacogenomics and Personalized Medicine 2013, 6:85-91
Published Date: 22 August 2013
Role of biomarkers in understanding and treating children with asthma: towards personalized care
Lang JE, Blake KV
Pharmacogenomics and Personalized Medicine 2013, 6:73-84
Published Date: 21 August 2013
ABCB1 haplotypes do not influence transport or efficacy of tyrosine kinase inhibitors in vitro
Skoglund K, Boiso Moreno S, Baytar M, Jönsson JI, Gréen H
Pharmacogenomics and Personalized Medicine 2013, 6:63-72
Published Date: 20 August 2013
Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia
El Rassi F, Khoury HJ
Pharmacogenomics and Personalized Medicine 2013, 6:57-62
Published Date: 5 August 2013
Molecular targeted therapies in metastatic melanoma
Chakraborty R, Wieland CN, Comfere NI
Pharmacogenomics and Personalized Medicine 2013, 6:49-56
Published Date: 7 June 2013
Association of CYP2D6 and CYP2C19 polymorphisms and disease-free survival of Thai post-menopausal breast cancer patients who received adjuvant tamoxifen
Chamnanphon M, Pechatanan K, Sirachainan E, Trachu N, Chantratita W, Pasomsub E, Noonpakdee W, Sensorn I, Sukasem C
Pharmacogenomics and Personalized Medicine 2013, 6:37-48
Published Date: 24 May 2013
Non-small-cell lung cancer: molecular targeted therapy and personalized medicine – drug resistance, mechanisms, and strategies
Sechler M, Cizmic AD, Avasarala S, Van Scoyk M, Brzezinski C, Kelley N, Bikkavilli RK, Winn RA
Pharmacogenomics and Personalized Medicine 2013, 6:25-36
Published Date: 4 April 2013
Copy number variation in sulfotransferase isoform 1A1 (SULT1A1) is significantly associated with enzymatic activity in Japanese subjects
Yu X, Kubota T, Dhakal I, Hasegawa S, Williams S, Ozawa S, Kadlubar S
Pharmacogenomics and Personalized Medicine 2013, 6:19-24
Published Date: 6 March 2013
GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer
Zhang X, Huang M, Wu X, Kadlubar S, Lin J, Yu X, Fan C, Ning B, Kadlubar FF
Pharmacogenomics and Personalized Medicine 2013, 6:9-17
Published Date: 1 March 2013
Importance of pharmacogenetics in the treatment of children with attention deficit hyperactive disorder: a case report
Tan-kam T, Suthisisang C, Pavasuthipaisit C, Limsila P, Puangpetch A, Sukasem C
Pharmacogenomics and Personalized Medicine 2013, 6:3-7
Published Date: 11 January 2013
Pharmacogenomic considerations in opioid analgesia. [Corrigendum]
Vuilleumier PH, Stamer UM, Landau R
Pharmacogenomics and Personalized Medicine 2013, 6:1-2
Published Date: 14 January 2013